This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
₹21.61
Share price
4.59%
Change (1 day)
-74.60%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): ₹56.85 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is ₹56.58 Million. In 2023 the company made a revenue of ₹1.24 Million a decrease over the revenue in the year 2022 that were of ₹22.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | ₹56.85 M | 4462.11% |
| 2023 | ₹1.24 M | -94.46% |
| 2022 | ₹22.51 M | |
| 2021 | N/A | -100% |
| 2020 | ₹2.73 M | -98.81% |
| 2019 | ₹0.22 B | -3.35% |
| 2018 | ₹0.23 B | -32.74% |
| 2017 | ₹0.35 B | -20.8% |
| 2016 | ₹0.44 B | 2.56% |
| 2015 | ₹0.43 B | -71.78% |
| 2014 | ₹1.53 B | 1104.64% |
| 2013 | ₹0.12 B | 29.74% |
| 2012 | ₹98.48 M | -66.11% |
| 2011 | ₹0.29 B | 35.15% |
| 2010 | ₹0.21 B | -13.48% |
| 2009 | ₹0.24 B | 169.83% |
| 2008 | ₹92.11 M | 55.88% |
| 2007 | ₹59.09 M | 42.82% |
| 2006 | ₹41.37 M | 114.87% |
| 2005 | ₹19.25 M | |
| 2004 | N/A | -100% |
| 2003 | ₹58.63 M | -24.09% |
| 2002 | ₹77.24 M | 195.12% |
| 2001 | ₹26.17 M |